CXI Healthcare Technology Group Limited (KOSDAQ:900120)
South Korea · Delayed Price · Currency is KRW 1,040.00
+120.00 (13.04%)
At close: Aug 24, 2026
KOSDAQ:900120 Market Cap
KOSDAQ:900120 has a market cap or net worth of 17.34 billion as of September 11, 2026. Its market cap has decreased by -3.55% in one year.
Market Cap
17.34B
Enterprise Value
-28.91B
Revenue
51.45B
Ranking
n/a
PE Ratio
0.16
Stock Price
1,040.00
ChartMarket Cap Chart
Since March 31, 2010, KOSDAQ:900120's market cap has decreased from 278.80B to 17.34B, a decrease of -93.78%. That is a compound annual growth rate of -15.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 17.34B | 9.24% |
| Dec 30, 2025 | 15.87B | -20.00% |
| Dec 30, 2024 | 19.84B | -34.87% |
| Dec 28, 2023 | 30.46B | -13.95% |
| Dec 29, 2022 | 35.40B | 16.62% |
| Dec 30, 2021 | 30.35B | -44.01% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmsville | 28.13B |
| HLscience | 27.15B |
| Daesung Microbiological Labs. | 23.41B |
| Baskhanbio Pharma | 23.30B |
| Seoul Pharma | 22.81B |
| BIFIDO | 22.45B |
| Hurum | 20.59B |
| Union Korea Pharm | 19.70B |